Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)

NCT03228342 is registered in ClinicalTrials.gov with Clínica de Artritis Temprana as lead sponsor.

NCT NCT03228342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)
Lead sponsor
Clínica de Artritis Temprana
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2017
Completion date
January 28, 2019
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal ultrasound, patient reported outcomes, rheumatoid arthritis